Histotripsy for advanced bile duct cancer
Treatments studied
This trial tests a new procedure called histotripsy that uses sound waves to destroy tumors in the bile ducts or gallbladder. It is for people whose cancer has spread and cannot be removed with surgery, and who have not yet had chemotherapy or other systemic treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You have bile duct or gallbladder cancer that has spread or is locally advanced and can't be removed with surgery.
- Your cancer has not been treated with systemic therapy (like chemotherapy) for the advanced disease.
- You have at least one tumor that is 3 cm or smaller and can be seen on ultrasound.
- You are generally able to function (ECOG performance status 0-2) and have adequate organ function.
- You have not had certain immune therapies before, and you don't have an active autoimmune disease or uncontrolled infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of chemotherapy, immunotherapy, and heat therapy (hyperthermia) with a special radiation technique for advanced bile duct or gallbladder cancer that hasn't been treated before. It aims to see if this combination can help shrink tumors and improve outcomes.
This study tests a combination of three drugs (gemcitabine, cisplatin, nab-paclitaxel) plus an immunotherapy (tislelizumab) for people with advanced biliary tract cancer who haven't had treatment yet. The goal is to see if this cocktail shrinks tumors better than standard care.
This trial tests a combination of chemotherapy drugs given directly into the liver, combined with two immunotherapy/targeted therapy drugs, for people with advanced biliary tract cancer (cancer of the bile ducts or gallbladder). The goal is to shrink tumors and improve survival in patients who have not received prior chemotherapy.
This trial is testing a new combination of treatments—a wearable device that sends electric fields to the tumor area (tumor-treating fields) plus immunotherapy (durvalumab) and chemotherapy (gemcitabine/cisplatin)—for people with advanced bile duct or gallbladder cancer. It may be an option if you haven't had chemotherapy for advanced disease before.
This trial tests a procedure that uses heat (radiofrequency ablation) to treat bile duct cancer that can't be removed by surgery. If you have this type of cancer and are starting standard treatment, this study wants to see if adding this heat treatment is safe and might help.
This trial tests a new treatment called BTC-Ag-T, which uses your own immune cells enhanced in the lab to fight advanced biliary tract cancer (cancer of the bile ducts or gallbladder). It's designed for patients whose cancer has spread or cannot be surgically removed and who have already received standard chemotherapy plus immunotherapy.
Hear when a new Biliary Track Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.